Latest Healthcare Research Reports

Category: Pharmaceuticals

What Is The Forecast Growth Rate For The Meningococcal Vaccines Market?
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The meningococcal vaccines market has seen rapid expansion in recent years, driven by various factors such as increased disease incidence, global travel trends, and improved healthcare infrastructure. This blog delves into the current market landscape, future projections, and significant trends shaping the market.

Current Market Landscape
- Market Size: The meningococcal vaccines market was valued at $3.57 billion in 2023.
- Growth Rate: Expected to reach $3.94 billion in 2024, growing at a compound annual growth rate (CAGR) of 10.5%.
Key Growth Drivers

Disease Incidence and Global Travel
- Rising cases of meningococcal disease worldwide.
- Increased global travel heightens the risk of disease spread.
Healthcare Infrastructure and Epidemic Preparedness
- Strengthened healthcare infrastructure supports broader vaccine distribution.
- Preparedness for potential epidemics fuels vaccine demand.
Health Insurance Coverage
- Improved health insurance coverage facilitates greater vaccine accessibility.
Read More On The Meningococcal Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

Future Projections
- Market Size: Projected to grow to $5.69 billion by 2028.
- Growth Rate: Expected CAGR of 9.6%.
Factors Driving Future Growth

Emergence of New Strains and Globalization
- New meningococcal strains necessitate updated vaccines.
- Increasing globalization further spreads disease risks.
Healthcare Investments and Health Initiatives
- Growing investments in healthcare enhance vaccine development and distribution.
- Initiatives promoting vaccination improve public health outcomes.
Regulatory Landscape
- Evolving regulations support the introduction of new vaccines.
Emerging Trends
- Personalized Vaccines: Tailored vaccines to improve efficacy and safety.
- Digital Vaccination Records: Streamlined tracking of vaccination status.
- Gene Editing Technologies: Advanced methods for developing effective vaccines.
- Multi-valent Vaccines: Vaccines targeting multiple serogroups.
- Subscription-Based Models: Innovative payment models for vaccine access.
Impact of Rising Healthcare Spending

Increased Healthcare Spending
- Significant rise in healthcare spending globally.
- Example: In the U.S., healthcare spending increased by 9.7% in 2022 to $4.1 trillion.
Economic Benefits of Vaccination
- Assessing the full social and economic benefits of vaccination is crucial.
- New vaccine generations often come with higher costs, necessitating a comprehensive evaluation of their value.
Major Companies in the Market
- Pfizer Inc.
- Johnson & Johnson Services Inc.
- Sinopharm Group Co Ltd.
- Merck & Co. Inc.
- Novartis AG
- Sanofi S.A.
- AstraZeneca PLC
- GlaxoSmithKline PLC
- Takeda Pharmaceutical Company Limited
- Baxter International Inc.
Pfizer’s Comprehensive Meningococcal Vaccine
- FDA Approval: Pfizer’s PENBRAYA vaccine received FDA approval in October 2023.
- Coverage: PENBRAYA protects against serogroups A, B, C, W, and Y.
- Clinical Trials: Demonstrated non-inferior immunogenicity and favorable safety compared to existing vaccines.
Strategic Acquisitions

GlaxoSmithKline’s Acquisition of Affinivax
- Acquisition Details: GSK acquired Affinivax Inc. for $3.3 billion in August 2022.
- Objective: Strengthening GSK’s portfolio in specialty medicines and vaccines.
- Affinivax’s Role: A next-generation vaccine technology company contributing to the meningococcal vaccines market.
Market Segmentation
1. By Vaccine Type:
  - Meningococcal Conjugate Vaccine
  - Polysaccharide Vaccine
  - Subcapsular Vaccine
2. By Serotype:
  - Men ACWY
  - Men B/Bc
  - Men C
3. By Age Group:
  - Infants
  - Children
  - Adolescents and Young Adults
  - Adults
4. By Distribution Channel:
  - Pharmacies
  - Community Clinics
  - Public Health Agencies
  - Other Channels
5. By End User:
  - Hospitals
  - Research
  - Academic Institutes
Regional Insights
- North America: The largest region in the meningococcal vaccines market in 2023.
- Asia-Pacific: Expected to be the fastest-growing region during the forecast period.
The meningococcal vaccines market is poised for significant growth, driven by advancements in healthcare, emerging disease strains, and strategic industry initiatives. As new trends and technologies emerge, the market will continue to evolve, ensuring better protection against meningococcal diseases worldwide.

Request for A Sample Of The Global Meningococcal Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8013&type=smp
June 3, 2024
Future Growth Forecast For The Medical Marijuana Global Market 2024-2033
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The medical marijuana market has seen unprecedented growth in recent years, with no signs of slowing down. This article delves into the factors driving this growth, the trends shaping the market, and the key players involved.

Rapid Market Expansion

Recent Growth
- 2023 to 2024: The market is projected to expand from $27.5 billion in 2023 to $33.3 billion in 2024, achieving a compound annual growth rate (CAGR) of 21.1%.
- Historical Drivers:
  - Changing regulatory landscape
  - Growing acceptance of cannabis for medical purposes
  - Expanding list of medical conditions
  - Patient demand for alternative therapies
  - Evolving attitudes among healthcare providers
Future Projections
- 2024 to 2028: The market is expected to soar to $72.9 billion by 2028, with a CAGR of 21.6%.
- Future Drivers:
  - Continued regulatory developments
  - Advances in scientific research and evidence
  - Increased patient education and awareness
  - Expansion of medical marijuana product offerings
  - Integration into mainstream healthcare
View More On The Medical Marijuana Market Report 2024 – https://www.thebusinessresearchcompany.com/report/medical-marijuana-global-market-report

Key Market Trends

Strategic Partnerships
- Partnerships with Traditional Healthcare Providers: Collaborations are forming to enhance product reach and credibility.
- Focus on Customized Treatment Plans: Tailored solutions are becoming more prevalent to meet specific patient needs.
- Standardization of Dosage and Labeling: Efforts are underway to ensure consistency and reliability in products.
- Investment and M&A Activity: Significant investments and mergers are consolidating the market and fostering innovation.
Impact of Cancer Prevalence
- Cancer Treatment: Medical marijuana is increasingly used to manage symptoms such as neuropathy, nausea, pain, vomiting, appetite loss, and weight loss.
- Rising Demand: With cancer cases on the rise (1.92 million new cases in the US in 2022), the demand for medical marijuana as an adjunctive therapy is growing.
Major Players in the Market
- Top Companies:
  - Pfizer Inc.
  - Curaleaf Holdings Inc.
  - Trulieve Cannabis Corp
  - Green Thumb Industries GTI Inc.
  - Cresco Labs Inc.
  - Tilray Inc.
  - Aphria Inc.
  - Canopy Growth Corporation
  - And many others
Strategic Partnerships
- Teva Pharmaceutical & Tikun Olam-Cannbit: Teva partnered with Tikun Olam-Cannbit in December 2021 to produce and market medical cannabis oils in Israel.
- Trulieve Cannabis Corp. & Connected Cannabis Co: In January 2022, Trulieve expanded its partnership with Connected Cannabis Co. to maintain a portfolio of proprietary top-shelf strains.
Major Acquisitions
- Jazz Pharmaceuticals & GW Pharmaceuticals: In May 2021, Jazz Pharmaceuticals acquired GW Pharmaceuticals, enhancing its portfolio with cannabinoid-based medications.
Market Segmentation

By Product
- Dried Flower
- Extract Form
By Type
- Flower
- Concentrate
- Edibles
- Other Types
By Application
- Pain Management
- Tourette Syndrome
- Alzheimer’s Disease
- Migraines
- Depression and Anxiety
- Multiple Sclerosis
- Cancer
- Other Applications
By Distribution Channel
- Retail Pharmacy
- E-Commerce
- Other Distribution Channels
Regional Insights
- North America: The largest market in 2023.
- Asia-Pacific: Expected to be the fastest-growing region during the forecast period.
Conclusion

The medical marijuana market is on a robust growth trajectory, driven by regulatory changes, scientific advancements, and increasing acceptance among both patients and healthcare providers. Strategic partnerships, acquisitions, and innovations in product offerings are shaping the future of this dynamic market, with significant opportunities for growth and development in the coming years.

Request A Sample Of The Global Medical Marijuana Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9091&type=smp
June 3, 2024
Comprehensive Analysis On Size, Share, And Drivers Of The Immunosuppressants Market
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The immunosuppressants market has witnessed rapid growth in recent years, with significant projections for the future. In 2023, it amounted to $25.94 billion and is expected to reach $29.72 billion by 2024, boasting a Compound Annual Growth Rate (CAGR) of 14.6%. This expansion is attributed to various factors, including advancements in transplant medicine, drug innovation, regulatory approvals, and increased transplant surgeries.

Future Projections and Growth Drivers
1. Forecasted Growth: The market is anticipated to further escalate, reaching $48.88 billion by 2028, with a CAGR of 13.2%.
2. Factors Driving Growth: Targeted therapies, precision medicine, biologics and biosimilars advancements, immunotherapy combinations, gene therapy, and drug delivery innovations are key contributors to this growth.
Impact of Rising Autoimmune Disease Cases
1. Increasing Prevalence: Autoimmune diseases are becoming more prevalent, contributing to the demand for immunosuppressants.
2. Elderly Population: With a growing elderly population globally, diseases like rheumatoid arthritis are becoming more common. For instance, in the US alone, the number of adults diagnosed with arthritis is projected to reach 78 million by 2040.
View More On The Immunosuppressants Market Report 2024 – https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Innovative Therapies Leading the Market
1. Focus on Innovation: Major companies are prioritizing the development of innovative drugs to address various conditions.
2. Example of Prograf: Astellas Pharma Inc.’s Prograf, a calcineurin inhibitor, received FDA approval for preventing organ rejection in lung transplant patients, marking a significant advancement in immunosuppressant therapy.
Amgen’s Strategic Acquisition
1. Expanding Portfolio: Amgen Inc.’s acquisition of ChemoCentryx Inc. for $3.7 billion in October 2022 expands its inflammation and nephrology drug portfolio.
2. Therapeutic Candidates: This acquisition provides Amgen with three therapeutic candidates targeting chemoattractant receptors and additional inflammatory conditions.
Segmentation of the Immunosuppressants Market
1. By Drug Class: The market is segmented into corticosteroids, monoclonal antibodies (mAbs), calcineurin inhibitors, mTOR inhibitors, anti-proliferative agents, and other drug classes.
2. By Indication: Segments include organ transplantation, autoimmune disorders, and non-autoimmune inflammatory diseases.
3. By Distribution Channel: Market distribution channels comprise hospital pharmacies, retail pharmacies, and online pharmacies.
Regional Dominance
1. North America: In 2023, North America emerged as the largest region in the immunosuppressants market, indicating significant market presence and growth opportunities.
In conclusion, the immunosuppressants market is witnessing remarkable growth driven by factors such as advancements in therapy, rising autoimmune diseases, and strategic industry moves. With innovations in drug development and a focus on precision medicine, the market is poised for substantial expansion in the coming years.

Request A Sample Of The Global Immunosuppressants Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3467&type=smp
May 31, 2024
Key Trends And Drivers In The Herbal Supplements Market 2024
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Growing Health Consciousness:
- Increasing number of health-conscious consumers is a key driver.
- Herbal supplements offer chemical-free alternatives for health maintenance.
- The trend is evident in surveys like the IFIC 2022 food and health survey, indicating a surge in health-focused behaviors among Americans.
Innovative Solutions Embrace Natural Ingredient Supplements For Holistic Health

Focus on Holistic Health:
- Major players develop innovative products like natural ingredient supplements.
- These supplements, derived from herbs, plants, or minerals, cater to holistic well-being.
- Example: Innov Healthcare Technologies’ Purobest emphasizes natural extracts like turmeric, green tea, and Boswellia serrata for combating chronic ailments.
GenTech Holdings Acquisition Of Nature Spoon LLC Expands Product Portfolio Into Herbal Supplement Lollipops

Strategic Acquisition:
- GenTech Holdings’ acquisition of Nature Spoon LLC broadens its product range.
- The acquisition introduces herbal supplement lollipops targeting children’s health.
- GenTech Holdings gains access to a new consumer segment and expands its geographic presence.
Read More On The Herbal Supplements Market Report 2024 – https://www.thebusinessresearchcompany.com/report/herbal-supplements-global-market-report

Segmentation Insights and Market Dynamics

Market Segmentation:
1. By Form: Tablets, Capsules, Liquid, Powder And Granules, Soft Gels
2. By Sources: Leaves, Fruits, Roots, Vegetables, Barks
3. By Application: Food And Beverages, Pharmaceuticals, Personal Care
4. By Distribution: Store Based, Non-Store Based
Regional Outlook:
- North America leads the herbal supplements market in 2023, driven by high consumer awareness.
- Asia-Pacific is poised to witness rapid growth, attributed to increasing health consciousness and a rich tradition of herbal remedies.
Key Players Driving Market Growth

Leading Companies:
- Archer Daniels Midland Company
- Glanbia PLC
- Herbalife Nutrition International of America Inc.
- NBTY Inc.
- Dabur India Ltd.
Notable Developments:
- Focus on natural ingredient supplements to meet consumer demand.
- Strategic acquisitions to diversify product portfolios and expand market reach.
Future Projections and Market Opportunities

Projected Growth:
- The herbal supplements market is forecasted to reach $66.77 billion by 2028.
- Continued consumer education and personalization drive market expansion.
Emerging Trends:
- Adoption of eco-friendly packaging solutions.
- Influence of cultural and traditional practices on product development.
- Collaborations and partnerships to enhance product offerings and distribution networks.
- Rising demand for personalized nutrition drives innovation in product diversity.
Conclusion

The herbal supplements market is witnessing significant growth, fueled by increasing health consciousness and demand for natural remedies. Major players are innovating with natural ingredient supplements to cater to holistic health needs. Strategic acquisitions and expansions into new product segments further drive market dynamics. With a diverse product range and expanding market reach, the future of herbal supplements holds promising opportunities for stakeholders across regions.

Request for A Sample Of The Global Herbal Supplements Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5894&type=smp
May 31, 2024
HER2 Inhibitors Market Forecast 2024: Forecast Market Size, Drivers And Key Segments
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The HER2 inhibitors market is experiencing robust growth, fueled by the rising incidence of breast cancer globally.
- Breast cancer ranks among the most prevalent cancer types, contributing significantly to new cancer diagnoses and fatalities.
- The surge in breast cancer cases underscores the demand for effective treatment options, driving the adoption of HER2 inhibitors.
- With projections indicating continued growth in breast cancer incidence, the HER2 inhibitors market is poised for substantial expansion.
Focus on Developing Treatment for HER2-Low Breast Cancer

Major companies in the HER2 inhibitors market are prioritizing the development of treatments for HER2-low breast cancer to gain a competitive edge.
- HER2-low breast cancer represents a newly defined subset of HER2-negative breast cancer, presenting unique treatment challenges.
- Regulatory approvals for therapies like Enhertu signify advancements in addressing HER2-low metastatic breast cancer.
- Innovative treatments targeting HER2-low breast cancer contribute to expanding treatment options and improving patient outcomes.
View More On The HER2 Inhibitors Market Report 2024 – https://www.thebusinessresearchcompany.com/report/her2-inhibitor-global-market-report

Strategic Acquisitions Drive Market Dynamics

Strategic acquisitions play a pivotal role in shaping the competitive landscape of the HER2 inhibitors market.
- Pfizer’s acquisition of Trillium Therapeutics enhances its leadership in oncology and strengthens its hematology portfolio.
- Trillium Therapeutics brings valuable expertise in developing cancer therapies, augmenting Pfizer’s capabilities in addressing blood cancers.
- Strategic collaborations and acquisitions facilitate market expansion and enable companies to offer comprehensive solutions to patients.
Market Segmentation and Regional Outlook

The HER2 inhibitors market is segmented based on treatment, application, and end-user, reflecting diverse therapeutic approaches and patient demographics.
1. Treatment: Monotherapy, Combination Therapy.
2. Application: Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Other Applications.
3. End User: Hospitals, Clinics, Other End Users.
Regional Dynamics:
- North America: Emerged as the largest region in the HER2 inhibitors market in 2023.
- Middle East: Expected to witness significant growth, driven by increasing healthcare investments and rising awareness about cancer treatment options.
Future Outlook

The HER2 inhibitors market is poised for strong growth, supported by advancements in precision medicine and increased focus on patient-centered care.
- The market is projected to reach $13.61 billion by 2028, with a compound annual growth rate (CAGR) of 9.0%.
- Major trends include patient advocacy, clinical research, and the integration of precision medicine approaches.
- Early detection and diagnosis, along with advancements in biomarker testing, will play a crucial role in improving treatment outcomes.
In conclusion, the HER2 inhibitors market’s robust growth trajectory underscores the industry’s commitment to addressing unmet medical needs in cancer treatment. With ongoing research, strategic collaborations, and advancements in precision medicine, stakeholders are poised to revolutionize cancer care and improve outcomes for patients worldwide.

Request A Sample Of The Global HER2 Inhibitors Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3396&type=smp
May 31, 2024
Top 5 Insights From The Fetal Bovine Serum Market Report 2024
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Fetal Bovine Serum Global Market Report 2024, the fetal bovine serum market is expected to show promising growth in the forecast period.

The fetal bovine serum (FBS) market has experienced substantial growth in recent years and is projected to continue expanding robustly. This blog delves into the market’s recent growth, future projections, and key trends that are shaping the industry’s trajectory.

Recent Market Growth

Market Size and Growth Rate
- 2023 Market Size: $1,095.25 billion
- 2024 Market Size: $1,176.47 billion
- CAGR (2023-2024): 7.4%
Historical Growth Drivers
- Biopharmaceutical Industry Expansion: Increased demand for FBS in drug development and production.
- Rise in Cell-Based Therapies: Growing use of cell therapies requiring high-quality FBS.
- Quality and Consistency Requirements: Demand for reliable and consistent FBS for research and clinical applications.
Future Market Projections

Projected Growth
- 2028 Market Size: $1,644.06 billion
- CAGR (2024-2028): 8.7%
Future Growth Drivers
- Adoption of Cell Therapies: Increased utilization of cell-based therapies in treating various diseases.
- Advanced Therapeutics Emergence: Development of new therapeutic modalities requiring FBS.
- Focus on Animal-Free Alternatives: Exploration of alternatives to traditional FBS.
- Strategic Supplier-Customer Relationships: Strengthened collaborations to ensure steady supply and innovation.
View More On The Fetal Bovine Serum Market Report 2024 – https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

Major Trends Shaping the Market

Focus on Quality and Traceability
- Ensuring high standards of quality and traceability in FBS production.
Global Collaboration and Partnerships
- Increased partnerships and collaborations across global markets to enhance supply chains and research capabilities.
Strategic Mergers and Acquisitions
- Ongoing mergers and acquisitions driving market consolidation and innovation.
Customized Fetal Bovine Serum Products
- Development of tailored FBS products to meet specific research and clinical needs.
Regulatory Compliance and Ethical Sourcing
- Adherence to stringent regulatory standards and ethical sourcing practices.
Surging Demand in the Biopharmaceutical Sector

Driving Market Growth
- Increased Biopharmaceutical Demand: Rising demand for biopharmaceuticals, driven by advancements in biologics research.
- Reliance on FBS: FBS is a critical component in cell culture media for biopharmaceutical production.
Case in Point
- ProClinical Limited (2022): Sales for pharmaceuticals and vaccines segments reached $36.15 million, an 11% YOY increase, reflecting the growing biopharmaceutical market’s impact on FBS demand.
Leading Companies and Innovations

Key Market Players
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Corning Incorporated
- Cytiva
- VWR International
- Sartorius AG
- GenClone Inc.
- Gemini Bio-Products
- Access Biologicals LLC
- Nucleus Biologics
- ZenBio Inc.
- Biowest
- Axil Scientific Pte Ltd.
Focus on USDA-Approved Products
- Thermo Fisher Scientific’s Gibco Fetal Bovine Serum: A USDA-approved, heat-inactivated product suitable for various research applications, reflecting the industry’s commitment to quality and safety.
Market Segmentation

By Product
- Charcoal Stripped
- Chromatographic
- Dialyzed Fetal Bovine Serum
- Exosome Depleted
- Stem Cell
- Other Products
By Application
- Drug Discovery
- Cell Culture Media
- In Vitro Fertilization
- Human and Animal Vaccine Production
- Diagnostics
- Other Applications
By End-User
- Research and Academic Institutes
- Biotechnology and Pharmaceutical Industry
- Other End-Users
Regional Insights

Largest Market
- North America: Leading the FBS market in 2023.
Fastest Growing Region
- Asia-Pacific: Expected to record the fastest growth during the forecast period.
Conclusion

The fetal bovine serum market is on a significant growth trajectory, driven by the expanding biopharmaceutical industry, rising cell-based therapies, and increasing demand for quality and consistency in research and clinical applications. As the market continues to evolve, strategic partnerships, innovation in product offerings, and adherence to regulatory standards will be crucial in shaping its future.

Request A Sample Of The Global Fetal Bovine Serum Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=4109&type=smp
May 30, 2024
Key Takeaways From The Global Erythropoietin (EPO) Market Forecast 2024
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Erythropoietin (EPO) Global Market Report 2024, the erythropoietin (EPO) market is expected to show significant growth in the forecast period.

The erythropoietin (EPO) market has experienced rapid growth in recent years and shows promising future prospects. With significant increases in market size and advancements in pharmaceutical research, this blog explores the factors driving this growth, future projections, and major trends that will shape the EPO market.

Recent Market Growth

Market Size and Growth Rate
- 2023 Market Size: $17.29 billion
- 2024 Market Size: $19.25 billion
- CAGR (2023-2024): 11.4%
Historical Growth Drivers
- Patient Education and Awareness: Increased awareness about EPO treatments and their benefits.
- Pharmaceutical Industry Consolidation: Mergers and acquisitions enhancing market capabilities.
- Healthcare Reimbursement Policies: Improved reimbursement policies supporting EPO treatments.
- Market Expansion and Demand Growth: Rising global demand for effective anemia treatments.
- Patent Expiration and Biosimilar Entry: Introduction of biosimilars boosting market competition.
View More On The Erythropoietin (EPO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

Future Market Prospects

Projected Growth
- 2028 Market Size: $30.92 billion
- CAGR (2024-2028): 12.6%
Future Growth Drivers
- Market Competition and Biosimilar Impact: Increased competition driving innovation and affordability.
- Disease Prevalence Projections: Higher incidence of diseases requiring EPO treatments.
- Healthcare Policy and Reimbursement Changes: Favorable policies enhancing market access.
- Emerging Markets Growth: Expansion in developing regions boosting overall market size.
- Clinical Trials and Research Focus: Ongoing research leading to new applications and treatments.
Major Trends Shaping the Future

Supply Chain Management
- Improvements in supply chain efficiency ensuring timely delivery of EPO products.
Global Expansion and Emerging Markets
- Entry into new geographic regions and markets driving overall growth.
Patient Education and Awareness
- Continued efforts to educate patients on the benefits and availability of EPO treatments.
Reimbursement Policies
- Enhanced policies improving patient access to EPO therapies.
Market Consolidation and Mergers
- Ongoing mergers and acquisitions fostering market stability and growth.
Rising Incidence of Chronic Kidney Diseases

Impact on EPO Market
- Chronic Kidney Disease (CKD) Incidence: Significant driver for EPO demand.
- CDC Report (2021): 15% of U.S. adults, or 37 million people, estimated to have CKD.
- Age Distribution: Higher CKD prevalence in older adults (38% in 65+ age group).
EPO in CKD Treatment
- EPO Role: Used to stimulate red blood cell production in CKD patients, addressing anemia and improving immunity.
Key Players in the EPO Market
- Associated British Foods PLC
- DuPont de Nemours Inc.
- Kerry Group PLC
- Firmenich SA
- Koninklijke DSM NV
- Dyadic International Inc.
- Novozymes A/S
- Endo International PLC
- Chr Hansen Holding A/S
- Advanced Enzyme Technologies Ltd.
- Catalyst Pharmaceuticals Inc.
- Codexis Inc.
- AB Enzymes GmbH
- Brain Biotech AG
- Sunson Industry Group Co. Ltd.
Innovations in Erythropoietin Market

Wanbang’s Yi Bao Breakthrough
- Product: Yi Bao (Human Erythropoietin for Injection)
- Approval: National Medical Products Administration (NMPA) approval in September 2021.
- Application: Treatment of anemia caused by chemotherapy in non-myeloid malignancies.
Market Segmentation

By Product
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Other Products
By Drug Class
- Biologics
- Biosimilars
By Application
- Cancer
- Hematology
- Renal Diseases
- Neurology
- Other Applications
Regional Insights
- Largest Market: North America
- Fastest Growing Region: Middle East (forecast period)
Conclusion

The erythropoietin market is set for substantial growth, driven by rising disease prevalence, advancements in healthcare policies, and increased competition from biosimilars. With continuous innovations and expanding global reach, the EPO market is poised to deliver significant benefits to patients worldwide, particularly those suffering from chronic kidney diseases and other related conditions.

Request A Sample Of The Global Erythropoietin (EPO) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3436&type=smp
May 30, 2024
Overview Of The Enzymes Market 2024-2033: Growth And Major Players Analysis
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The enzymes market has seen substantial growth in recent years, driven by globalization, technological advancements, and increasing consumer awareness. This blog explores the market’s recent expansion, future projections, key trends, and the impact of rising digestive disorders on market growth.

Recent Market Growth
Market Size and Growth Rate
- 2023 Market Size: $11.78 billion
- 2024 Market Size: $13.52 billion
- CAGR (2023-2024): 14.8%
Historical Growth Drivers
- Globalization and market expansion
- Increased research and development investments
- Rising consumer awareness and demand
- Improvements in bioprocessing technology
- Focus on waste reduction and recycling
View More On The Enzymes Market Report 2024 – https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Future Market Prospects
Projected Growth
- 2028 Market Size: $22.86 billion
- CAGR (2024-2028): 14.0%
Future Growth Drivers
- Market demand dynamics
- Emphasis on sustainable practices
- Health and nutrition trends
- Growth in biofuel and renewable energy sectors
- Emerging applications in various industries
Major Trends Shaping the Future
Biotechnology Advancements
- Enhanced enzyme production techniques
- Development of new enzyme formulations for specific applications
Sustainability Demands
- Increasing use of enzymes in waste management and recycling
- Adoption of eco-friendly enzymatic processes in industries
Food and Beverage Industry Demand
- Enzymes used to improve food quality and shelf-life
- Rising demand for natural and organic food products
Expansion of Industrial Applications
- Enzymes in textiles, detergents, and biofuel production
- Growth in enzyme applications in pharmaceuticals and cosmetics
Consumer Preference for Natural Products
- Shift towards natural and organic products driving enzyme use
- Increased focus on health and wellness among consumers
Surge in Digestive Disorders and Market Growth
Impact of Digestive Disorders
- Rise in digestive disorders like GERD, IBS, and lactose intolerance increases demand for digestive enzymes
- Enzymes help break down food for better absorption, addressing digestive health issues
Statistics Highlighting the Trend
- October 2022: National Center for Biotechnology Information (NCBI) reported 10-15% prevalence of IBS in the U.S.
- Nearly 12% of patients seek medical care for IBS-related complaints
Key Players in the Enzymes Market
- ERM Group Limited
- WSP Global Inc.
- SNC-Lavalin Group Inc.
- Wood PLC
- Stantec Inc.
- Black & Veatch Corporation
- Tetra Tech Inc.
- Cardno Limited
- CH2M HILL Engineers Inc.
- Geosyntec Consultants LLC
- Apex Companies Inc.
- GZA GeoEnvironmental Technologies Inc.
- Haley & Aldrich Inc.
- Intelex Corporation
- iAuditor Inc.
Innovative Enzyme-Based Medications
Lamzede for Alpha-Mannosidosis
- Company: Chiesi Global Rare Diseases
- FDA Approval: May 2023
- Application: Treats non-neurological symptoms of alpha-mannosidosis
- Technology: Recombinant DNA technology using mammalian CHO cells
Strategic Acquisitions
AstraZeneca and CinCor Pharma Inc.
- Acquisition: February 2023
- Value: $1.3 billion
- Purpose: Bolster cardiorenal pipeline with CinCor’s drug, baxdrostat (CIN-107)
- Focus: Enzyme-based therapeutics for treatment-resistant hypertension
Market Segmentation
By Product Type
- Asparaginase
- Lipase
- Protease
- Nattokinase
- Chitinase
- Serratiopeptidase
- Collagenase
- Ligase
- Other Products
By Application
- Leukemia
- Stomach Disorders
- Antitumor
- Skin Ulcers
- Gaucher Disease
- Fabry Disease
- Other Applications
By End User
- Drug Manufacturers
- Hospitals
- Private Clinics
- Research Laboratories
Regional Insights
- North America: Largest region in the enzymes market in 2023
Conclusion
The enzymes market is experiencing rapid growth, driven by advancements in biotechnology, rising consumer demand for natural products, and the increasing prevalence of digestive disorders. With significant innovations and strategic acquisitions, major companies are enhancing their market positions and product offerings. The future of the enzymes market looks promising, with robust growth expected across various regions and applications.

Request A Sample Of The Global Enzymes Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3425&type=smp
May 30, 2024
Hand Cream and Hand Lotion Market Forecast 2024: Forecast Market Size, Drivers And Key Segments
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The hand cream and lotion market is witnessing robust growth, driven by various factors including heightened hygiene awareness, evolving consumer preferences, and innovative product offerings. Let’s delve into the dynamics shaping this flourishing sector.

Unveiling Market Growth Trends
- The hand cream and lotion market has experienced significant expansion:
  - Growing from $7.8 billion in 2023 to $8.53 billion in 2024 at a CAGR of 9.4%
  - Forecasted to reach $13.3 billion in 2028 at a CAGR of 11.7%
The Rise of Hand Hygiene
- Increasing emphasis on hand hygiene fuels demand for hand creams and lotions:
  - Frequent hand washing, essential for reducing COVID-19 transmission, leads to dryness and irritation
  - Healthcare professionals recommend hand creams to nourish and protect the skin, driving market growth
View More On The Hand Cream and Hand Lotion Market Report 2024 – https://www.thebusinessresearchcompany.com/report/hand-cream-and-hand-lotions-global-market-report

Leading Players in the Market
- Major companies driving innovation in hand care include:
  - Johnson & Johnson
  - Procter & Gamble Company
  - Unilever PLC
  - L’Oréal SA
  - Henkel AG & Co. KGaA
Age-Defying Formulations to Combat Aging Signs
- Focus on age-defying lotions as a competitive edge:
  - Targeting signs of aging such as wrinkles and age spots
  - Example: Bota Hemp’s CBD-infused hand lotion for hydration and skin rejuvenation
Strategic Acquisitions and Market Expansion
- Companies are expanding their portfolios through strategic acquisitions:
  - Example: Edgewell Personal Care’s acquisition of Billie Inc., strengthening its presence in the women’s shaving market and expanding product offerings
Market Segmentation and Product Innovation
- The hand cream and lotion market is segmented based on:
  - Types including moisturizing, protective, and repair formulations
  - Applications catering to adults and babies
  - Distribution channels encompassing supermarkets, specialty stores, and online platforms
Incorporating Innovation and Sustainability
- Key trends driving market growth include:
  - Inclusion of CBD and botanical extracts for enhanced benefits
  - Innovative application methods for user convenience
  - Multifunctional products addressing various skin concerns
  - Emphasis on sustainability in packaging and ingredients
Regional Insights
- North America leads the hand cream and lotion market in 2023:
  - Driven by increased awareness and adoption of skincare products
- Asia-Pacific emerges as a region of significant growth potential:
  - Rising hygiene awareness and expanding consumer base contribute to market expansion
Conclusion: Embracing Hand Care as Essential Skincare

The hand cream and lotion market continues to thrive, propelled by evolving consumer needs and industry innovations. As companies focus on product development, sustainability, and strategic partnerships, the sector is poised for sustained growth. With an emphasis on hand hygiene and skincare, hand creams and lotions have become essential staples in personal care routines, ensuring nourished and protected hands for consumers worldwide.

Request A Sample Of The Global Hand Cream and Hand Lotion Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3454&type=smp
May 30, 2024
Growth Trajectory Of The Corticosteroids Market 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The corticosteroids market has experienced steady growth in recent years and is poised for further expansion. This blog explores the current market dynamics, future projections, key trends, and innovations driving this sector.

Market Overview

Current Market Size
- Growth from 2023 to 2024:
  - Increased from $5.47 billion in 2023 to $5.7 billion in 2024.
  - Compound annual growth rate (CAGR) of 4.1%.
- Factors Driving Growth:
  - Treatment of inflammatory conditions and autoimmune disorders.
  - Immune system suppression, asthma management, allergic reactions, dermatological applications, and cancer treatment support.
Future Projections

Expected Market Growth
- Forecasted Growth to 2028:
  - Projected to reach $7.24 billion by 2028.
  - CAGR of 6.2% during the forecast period.
- Growth Drivers:
  - Rising incidence of chronic diseases.
  - Expanding applications in rheumatology.
  - Advancements in drug delivery.
  - Growth of the geriatric population.
  - Research and development in corticosteroid therapeutics.
View More On The Corticosteroids Market Report 2024 – https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Key Trends Shaping the Market

Immunomodulatory Effects and Biosimilars
- Immunomodulatory Emphasis:
  - Increasing focus on the immunomodulatory effects of corticosteroids.
- Biosimilar Market Growth:
  - Rise in biosimilar products, offering cost-effective alternatives.
Combination Therapies and Pediatric Formulations
- Combination Therapies:
  - Development of combination therapies to enhance treatment efficacy.
- Pediatric-Specific Formulations:
  - Introduction of formulations tailored for pediatric use.
Regulatory Compliance
- Focus on Compliance:
  - Emphasis on adhering to regulatory standards to ensure safety and efficacy.
Rising Incidence of Skin Conditions

Demand for Corticosteroids
- Increasing Skin-Related Diseases:
  - Rise in conditions such as rashes, dermatitis, itching, eczema, and psoriasis.
  - For instance, the CDC reports at least 2 million people in the US are infected with antibiotic-resistant bacteria annually, with 23,000 deaths.
- Skin Cancer Prevalence:
  - According to Cleveland Clinic, nearly one in five Americans will develop skin cancer, with 9,500 diagnoses daily.
Impact on Market
- Increased Demand:
  - Higher prevalence of skin disorders driving demand for corticosteroids.
- Market Growth:
  - Significant contribution to the overall market growth.
Innovative Rescue Medication Developments

New Product Launches
- Rescue Medications:
  - Quick relief from acute and severe symptoms of medical conditions.
- Example:
  - In January 2023, AstraZeneca launched Airsupra (albuterol/budesonide), a first-in-class pressurized metered-dose inhaler for bronchoconstriction and asthma management.
Market Impact
- Customer Base Expansion:
  - Innovative products catering to larger customer bases.
- Revenue Growth:
  - Increase in sales and revenue through novel product offerings.
Strategic Acquisitions

Sanofi and Flexion Therapeutics
- Potential Acquisition:
  - Sanofi’s talks to acquire Flexion Therapeutics, enhancing its biosurgery division.
- Zilretta:
  - Flexion’s sustained-release corticosteroid for osteoarthritis, potentially reaching blockbuster status.
Market Segmentation

Product and Application Segments
- By Product:
  - Glucocorticoids, Mineralocorticoids.
- By Application:
  - Skin allergies, rheumatology indications, endocrinology, acute respiratory diseases, other applications.
End User Segments
- End Users:
  - Hospitals, clinics, research institutes, other end users.
Regional Insights

Market Distribution
- North America:
  - Largest region in corticosteroids market share in 2023.
- Middle East:
  - Expected to be the fastest-growing region during the forecast period.
The corticosteroids market is set for strong growth, driven by the rising incidence of chronic diseases, advancements in drug delivery, and strategic industry movements. With continued innovation and expanding applications, the market is poised to meet increasing global demand effectively.

Request A Sample Of The Global Corticosteroids Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=2832&type=smp
May 29, 2024